BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

895 related articles for article (PubMed ID: 17959934)

  • 1. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
    Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
    Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.
    Thallas-Bonke V; Coughlan MT; Bach LA; Cooper ME; Forbes JM
    Am J Nephrol; 2010; 32(1):73-82. PubMed ID: 20551625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression.
    Li L; Renier G
    Metabolism; 2006 Nov; 55(11):1516-23. PubMed ID: 17046555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.
    Nam SM; Lee MY; Koh JH; Park JH; Shin JY; Shin YG; Koh SB; Lee EY; Chung CH
    Diabetes Res Clin Pract; 2009 Feb; 83(2):176-82. PubMed ID: 19111363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress mediates protein kinase C activation and advanced glycation end product formation in a mesangial cell model of diabetes and high protein diet.
    Tuttle KR; Anderberg RJ; Cooney SK; Meek RL
    Am J Nephrol; 2009; 29(3):171-80. PubMed ID: 18781061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease.
    Peng F; Wu D; Gao B; Ingram AJ; Zhang B; Chorneyko K; McKenzie R; Krepinsky JC
    Diabetes; 2008 Jun; 57(6):1683-92. PubMed ID: 18356410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of NAD(P)H oxidase alleviates impaired NOS-dependent responses of pial arterioles in type 1 diabetes mellitus.
    Mayhan WG; Arrick DM; Sharpe GM; Patel KP; Sun H
    Microcirculation; 2006; 13(7):567-75. PubMed ID: 16990215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of reactive oxygen species from isolated rat glomeruli by protein kinase C activation and TNF-alpha stimulation, and effects of a phosphodiesterase inhibitor.
    Koike N; Takamura T; Kaneko S
    Life Sci; 2007 Apr; 80(18):1721-8. PubMed ID: 17346751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comment on: Thallas-Bonke et al. (2008) Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway: Diabetes 57:460-469, 2008.
    Yamagishi S
    Diabetes; 2008 Jun; 57(6):e13; author reply e14. PubMed ID: 18511442
    [No Abstract]   [Full Text] [Related]  

  • 10. Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase.
    Wei XF; Zhou QG; Hou FF; Liu BY; Liang M
    Am J Physiol Renal Physiol; 2009 Feb; 296(2):F427-37. PubMed ID: 19019916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: involvement of Nox2 (gp91phox)-containing NADPH oxidase.
    Zhang M; Kho AL; Anilkumar N; Chibber R; Pagano PJ; Shah AM; Cave AC
    Circulation; 2006 Mar; 113(9):1235-43. PubMed ID: 16505175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of NADPH oxidase in retinal microvascular permeability increase by RAGE activation.
    Warboys CM; Toh HB; Fraser PA
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1319-28. PubMed ID: 18997095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats.
    Soetikno V; Watanabe K; Sari FR; Harima M; Thandavarayan RA; Veeraveedu PT; Arozal W; Sukumaran V; Lakshmanan AP; Arumugam S; Suzuki K
    Mol Nutr Food Res; 2011 Nov; 55(11):1655-65. PubMed ID: 22045654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
    Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
    Nakamura S; Tachikawa T; Tobita K; Aoyama I; Takayama F; Enomoto A; Niwa T
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NADPH oxidase inhibitor, apocynin, restores the impaired endothelial-dependent and -independent responses and scavenges superoxide anion in rats with type 2 diabetes complicated by NO dysfunction.
    Hayashi T; Juliet PA; Kano-Hayashi H; Tsunekawa T; Dingqunfang D; Sumi D; Matsui-Hirai H; Fukatsu A; Iguchi A
    Diabetes Obes Metab; 2005 Jul; 7(4):334-43. PubMed ID: 15955119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of renal gluconeogenesis contributes to hypoglycaemic action of NADPH oxidase inhibitor, apocynin.
    Winiarska K; Grabowski M; Rogacki MK
    Chem Biol Interact; 2011 Jan; 189(1-2):119-26. PubMed ID: 20934416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High glucose activates PKC-zeta and NADPH oxidase through autocrine TGF-beta1 signaling in mesangial cells.
    Xia L; Wang H; Munk S; Kwan J; Goldberg HJ; Fantus IG; Whiteside CI
    Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1705-14. PubMed ID: 18815221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of NADPH oxidase inhibitor in diabetic nephropathy.
    Asaba K; Tojo A; Onozato ML; Goto A; Quinn MT; Fujita T; Wilcox CS
    Kidney Int; 2005 May; 67(5):1890-8. PubMed ID: 15840036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat.
    Zhang Y; Chan MM; Andrews MC; Mori TA; Croft KD; McKenzie KU; Schyvens CG; Whitworth JA
    Am J Hypertens; 2005 Jul; 18(7):910-6. PubMed ID: 16053986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.